Page last updated: 2024-09-04

ertapenem and Bacterial Disease

ertapenem has been researched along with Bacterial Disease in 60 studies

Research

Studies (60)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	42 (70.00)	29.6817
2010's	14 (23.33)	24.3611
2020's	4 (6.67)	2.80

Authors

Authors	Studies
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Burnham, CD; Eberly, AR; Heitman, AK; Jean, S; Schuetz, AN; Shannon, S; Wallace, MA	1
Albrecht, MT; Bergmann, JN; Homer, MJ; Phipps, AJ; Singh, VK	1
Abdelmegeed, AA; Abo Kamer, AM; Amer, NM; El Maghraby, GM; Gamaleldin, NM	1
Fowler, MA; Patel, UC	1
Decloedt, EH; Dramowski, A; Finlayson, H; Koopmans, LR; Whitelaw, A	1
Abad, A; Aguilera, A; Escalada, C; Estrada, O; García, D; Gómez, MJ; González, CR; González, S; González-Ramallo, VJ; Mirón-Rubio, M; Mujal, A; Muñoz, P; Pajarón, M; Parra, JJ; Pereda, I; Sampedro, I; Sanroma, P; Sgaramella, GA; Solé, A; Vitoria, I	1
Batty, KT; Chambers, J; Davis, TME; Dyer, J; Manning, L; Page-Sharp, M; Salman, S	1
Bobola, V; Forbes, W; Frazier, W; Joyner, ML; Manning, CC	1
Baldolli, A; Colin, E; Saint-Lorant, G; Verdon, R	1
Kim, DH; Yoon, H	1
Carvalho, VC; Lima, AL; Oliveira, PR; Peixoto de Miranda, EJ	1
Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A	1
Chemaly, RF; Mahajan, SN; Nesher, L; Rolston, KV; Tverdek, FP	1
Gan, WJ; Mu, SM; Ran, XW; Shen, JF; Wang, J; Xian, Y; Xu, ZR; Yan, XD; Yuan, GY; Zhang, BS	1
Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L	1
Gobernado, M; González-Esteban, J; Redondo, E; Sanz-Rodríguez, C; Torroba, L; Villanueva, R	1
Levin, AS; Oliveira, MS	1
Ansaloni, L; Catena, F; Gazzotti, F; Nanetti, A; Nardo, B; Pezzilli, R; Pinna, AD; Santini, D	1
Abramson, MA; Citron, DM; Goldstein, EJ; Merriam, CV	1
Carmeli, Y; Jansen, JP; Kumar, R	1
An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z	1
Ansaloni, L; Catena, F; Coccolini, F; Di Saverio, S; Ercolani, G; Gazzotti, F; Lazzareschi, D; Pinna, AD	1
Beloborodov, VB	1
Burian, A; Burian, B; Höferl, M; Jäger, W; Riedl, M; Sauermann, R; Stella, A; Theurer, S; Zeitlinger, M	1
Adeyi, B; Fernandez, A; Geib, J; Hassett, JM; Teppler, H; Woods, GL; Yellin, AE	1
Citron, DM; Goldstein, EJ; Motyl, M; Pelak, BA; Teppler, H; Woods, GL	1
Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL	1
Cunha, BA	1
Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL	1
Livermore, DM; Scott, GM; Sefton, AM	1
Curran, M; Perry, C; Simpson, D	1
Karpov, OI; Strekachev, AIu; Zaĭtsev, AA	1
Meibohm, AR; Teppler, H; Woods, GL	1
Hammond, ML	1
Wexler, HM	1
DiNubile, MJ; Majumdar, AK; Nix, DE	1
Goldstein, EJ; Snydman, DR	1
Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL	1
Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL	1
Tice, AD	1
Goldstein, EJ	1
Brink, AJ; Feldman, C; Grolman, DC; Muckart, D; Pretorius, J; Richards, GA; Senekal, M; Sieling, W	1
Alhambra, A; Alós, JI; Gómez-Garcés, JL; Hernáiz, C	1
Keating, GM; Perry, CM	1
Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B	1
Baek, JY; Heo, ST; Ko, KS; Kwon, KT; Lee, JY; Lee, MY; Lee, NY; Oh, WS; Park, S; Peck, KR; Ryu, SY; Song, JH	1
Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S	1
Burkhardt, O; Derendorf, H; Welte, T	1
Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE	1
Abramson, MA; Armstrong, DG; Lipsky, BA; Polis, AB; Sheehan, P; Tice, AD	1
Dilay, L; Hoban, DJ; Karlowsky, JA; Noreddin, AM; Rubinstein, E; Thomson, K; Wiebe, R; Zhanel, GG	1
Abramson, MA; Hoey, CT; Lipsky, BA; Tice, AD; Turpin, RS; Wu, J	1
Brink, AJ; Feldman, C; Richards, GA	1
Arrieta, AC; Congeni, BL; Fernsler, D; Gesser, R; Higareda, I; Johnson, J; West, J; Yellin, AE	1
Lister, PD	1
Acuña, C; Gobernado, M	1
Falagas, ME; Karageorgopoulos, DE; Makris, GC; Matthaiou, DK; Peppas, G	1
Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H	1

Reviews

19 review(s) available for ertapenem and Bacterial Disease

Article	Year
Subcutaneously administered antibiotics. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:3 Topics: Age Factors; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Clinical Trials as Topic; Cohort Studies; Ertapenem; Humans; Infusions, Intravenous; Injections, Intravenous; Injections, Subcutaneous; Microbial Sensitivity Tests; Teicoplanin	2020
[Microbiology of diabetic foot infections: role of ertapenem]. Drugs of today (Barcelona, Spain : 1998), 2013, Volume: 49 Suppl A Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests	2013
The challenge of multidrug resistance: the treatment of gram-negative rod infections. Shock (Augusta, Ga.), 2008, Volume: 30 Suppl 1 Topics: Acinetobacter; Bacterial Infections; beta-Lactamases; beta-Lactams; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Ertapenem; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Pseudomonas aeruginosa; Sulbactam; Tigecycline	2008
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC infectious diseases, 2009, Dec-02, Volume: 9 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2009
Ertapenem. A review of its microbiologic, pharmacokinetic and clinical aspects. Drugs of today (Barcelona, Spain : 1998), 2002, Volume: 38, Issue:3 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Child; Drug Interactions; Ertapenem; Humans; Infusions, Intravenous; Lactams	2002
Properties and potential of ertapenem. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Drug Resistance, Bacterial; Ertapenem; Half-Life; Humans; Lactams	2003
Ertapenem: a review of its use in the management of bacterial infections. Drugs, 2003, Volume: 63, Issue:17 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams	2003
[New approaches to antibacterial therapy of infections in the surgical practice]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2003, Volume: 48, Issue:5 Topics: Abdominal Abscess; Aza Compounds; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Cross Infection; Ertapenem; Fluoroquinolones; Humans; Lactams; Moxifloxacin; Quinolines; Randomized Controlled Trials as Topic; Surgical Wound Infection	2003
Ertapenem: a Group 1 carbapenem with distinct antibacterial and pharmacological properties. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Ertapenem; Humans; Lactams	2004
In vitro activity of ertapenem: review of recent studies. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests	2004
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Renal Insufficiency	2004
Safety and tolerability of ertapenem. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic	2004
Appropriate use of the carbapenems. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2004, Volume: 94, Issue:10 Pt 2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Cilastatin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Ertapenem; Humans; Imipenem; Lactams; Meropenem; Patient Selection; Pneumonia, Bacterial; Practice Patterns, Physicians'; Protease Inhibitors; South Africa; Surgical Wound Infection; Thienamycins; Urinary Tract Infections	2004
Ertapenem: a review of its use in the treatment of bacterial infections. Drugs, 2005, Volume: 65, Issue:15 Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Drug Resistance, Bacterial; Ertapenem; Humans; Infant	2005
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections	2007
Comparative review of the carbapenems. Drugs, 2007, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Doripenem; Ertapenem; Humans; Imipenem; Meropenem; Thienamycins	2007
Carbapenems in the USA: focus on doripenem. Expert review of anti-infective therapy, 2007, Volume: 5, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Structure-Activity Relationship; Thienamycins; United States	2007
[Ertapenem]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Cell Wall; Child; Diabetes Complications; Double-Blind Method; Drug Costs; Drug Synergism; Ertapenem; Female; Humans; Male; Obesity; Pregnancy; Randomized Controlled Trials as Topic; Tissue Distribution	2007
Meta-analysis: ertapenem for complicated intra-abdominal infections. Alimentary pharmacology & therapeutics, 2008, Volume: 27, Issue:10 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2008

Trials

11 trial(s) available for ertapenem and Bacterial Disease

Article	Year
Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactams; China; Diabetic Foot; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Ertapenem; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Young Adult	2016
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial. JAMA surgery, 2017, 03-01, Volume: 152, Issue:3 Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult	2017
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis. Surgical infections, 2009, Volume: 10, Issue:2 Topics: Antibiotic Prophylaxis; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Cefotetan; Colon; Elective Surgical Procedures; Ertapenem; Humans; Microbial Sensitivity Tests; Rectum; Surgical Wound Infection; Treatment Failure	2009
A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapene BMC gastroenterology, 2011, Apr-18, Volume: 11 Topics: Abdomen; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Drug Therapy, Combination; Ertapenem; Humans; Peritonitis; Sulbactam	2011
Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. International journal of antimicrobial agents, 2002, Volume: 20, Issue:3 Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Humans; Injections, Intravenous; Lactams; Male; Metronidazole; Middle Aged	2002
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections. Surgical infections, 2002,Winter, Volume: 3, Issue:4 Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection	2002
Management of complicated appendicitis and comparison of outcome with other primary sites of intra-abdominal infection: results of a trial comparing ertapenem and piperacillin-tazobactam. Journal of chemotherapy (Florence, Italy), 2004, Volume: 16, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Colonic Diseases; Demography; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Risk Factors; Severity of Illness Index	2004
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome	2004
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2006, Volume: 10, Issue:4 Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome	2006
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults. Surgical infections, 2007, Volume: 8, Issue:1 Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination	2007
Ertapenem or ticarcillin/clavulanate for the treatment of intra-abdominal infections or acute pelvic infections in pediatric patients. American journal of surgery, 2007, Volume: 194, Issue:3 Topics: Abdominal Cavity; Acute Disease; Adolescent; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Child, Preschool; Clavulanic Acids; Ertapenem; Female; Humans; Male; Pelvis; Prospective Studies; Ticarcillin	2007

Other Studies

30 other study(ies) available for ertapenem and Bacterial Disease

Article	Year
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests	2008
Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis. Journal of clinical microbiology, 2022, 04-20, Volume: 60, Issue:4 Topics: Anaerobiosis; Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Bacteroides fragilis; beta-Lactamases; Carbapenems; Ertapenem; Humans; Microbial Sensitivity Tests; Reproducibility of Results	2022
Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose. Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10 Topics: Acute Radiation Syndrome; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefepime; Enrofloxacin; Ertapenem; Gentamicins; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Linezolid; Radiation Dosage	2022
Surfactant nanovesicles for augmented antibacterial activity against carbapenemase resistant enterobacteriaceae and extended spectrum beta-lactamases producing bacteria: in vitro and in vivo evaluation. BMC microbiology, 2023, 03-16, Volume: 23, Issue:1 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Enterobacteriaceae; Ertapenem; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Surface-Active Agents	2023
Ertapenem-associated neurotoxicity in the spinal cord injury (SCI) population: A case series. The journal of spinal cord medicine, 2018, Volume: 41, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Ertapenem; Hallucinations; Humans; Male; Middle Aged; Neurotoxicity Syndromes; Spinal Cord Injuries	2018
Paediatric antimicrobial use at a South African hospital. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 74 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Child; Community-Acquired Infections; Cross Infection; Ertapenem; Female; Hospitalization; Hospitals; Humans; Infant; Intensive Care Units, Pediatric; Male; Medical Overuse; Meropenem; Pediatrics; Pharmacies; South Africa	2018
Effectiveness and safety of ertapenem used in hospital-at-home units: data from Spanish Outpatient Parenteral Antimicrobial Therapy Registry. Future microbiology, 2018, Volume: 13 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cohort Studies; Ertapenem; Female; Hispanic or Latino; Home Care Services, Hospital-Based; Humans; Male; Middle Aged; Nursing Homes; Outpatients; Registries; Retrospective Studies; Self Administration	2018
Ertapenem for osteoarticular infections in obese patients: a pharmacokinetic study of plasma and bone concentrations. European journal of clinical pharmacology, 2019, Volume: 75, Issue:4 Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Bone and Bones; Bone Diseases, Infectious; Ertapenem; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Obesity; Off-Label Use; Prospective Studies	2019
Modeling Ertapenem: the impact of body mass index on distribution of the antibiotic in the body. Mathematical biosciences and engineering : MBE, 2019, 01-15, Volume: 16, Issue:2 Topics: Algorithms; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Body Mass Index; Body Weight; Carbapenems; Computer Simulation; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Models, Theoretical; Obesity; Thinness	2019
Unusual drug reaction between valproate sodium and meropenem. International journal of clinical pharmacy, 2013, Volume: 35, Issue:3 Topics: Aged; Anti-Bacterial Agents; Anticonvulsants; Bacterial Infections; beta-Lactams; Drug Interactions; Drug Monitoring; Epilepsy; Ertapenem; Humans; Male; Meropenem; Thienamycins; Valproic Acid	2013
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience. Journal of chemotherapy (Florence, Italy), 2013, Volume: 25, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins	2013
Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. Infection, 2015, Volume: 43, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Drug Utilization; Ertapenem; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Young Adult	2015
[In vitro activity of ertapenem against clinical bacterial isolates in 69 Spanish medical centers (E-test study)]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2007, Volume: 20, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Community-Acquired Infections; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Spain	2007
Effect of early antibiotic prophylaxis with ertapenem and meropenem in experimental acute pancreatitis in rats. Journal of hepato-biliary-pancreatic surgery, 2009, Volume: 16, Issue:3 Topics: Animals; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Ertapenem; Male; Meropenem; Pancreatitis, Acute Necrotizing; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Thienamycins	2009
Accounting for the development of antibacterial resistance in the cost effectiveness of ertapenem versus piperacillin/tazobactam in the treatment of diabetic foot infections in the UK. PharmacoEconomics, 2009, Volume: 27, Issue:12 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cost-Benefit Analysis; Decision Trees; Diabetic Foot; Direct Service Costs; Drug Costs; Drug Resistance, Bacterial; Ertapenem; Humans; Models, Biological; Models, Econometric; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom	2009
[Characteristics of ertapenem use in critical state patients]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:3-4 Topics: Abdominal Cavity; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lung; Microbial Sensitivity Tests; Skin; Time Factors; Tissue Distribution	2011
Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Male; Middle Aged; Plasma; Skin; Young Adult	2013
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection. The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5 Topics: Acute Disease; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pelvic Infection	2002
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes	2002
Intra-abdominal infections: review of the bacteriology, antimicrobial susceptibility and the role of ertapenem in their therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Abdomen; Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Microbial Sensitivity Tests; Middle Aged; Rats	2004
Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Ambulatory Care; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Infusions, Intravenous; Lactams; Outpatients; Self Administration	2004
Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Ertapenem; Humans; Lactams	2004
[Activity of ertapenem and 19 other antimicrobial agents against beta-lactam-resistant Streptococcus pneumoniae and Haemophilus influenzae respiratory tract isolates]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactams; Child; Drug Resistance, Multiple, Bacterial; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Spain; Streptococcus pneumoniae	2005
In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries. Diagnostic microbiology and infectious disease, 2006, Volume: 56, Issue:4 Topics: Anti-Bacterial Agents; Asia; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Sentinel Surveillance; Streptococcus pneumoniae	2006
Bactericidal activity of ertapenem against major intra-abdominal pathogens. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors	2006
Clinical predictors of treatment failure for diabetic foot infections: data from a prospective trial. International wound journal, 2007, Volume: 4, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Ertapenem; Female; Humans; Leukocyte Count; Male; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Severity of Illness Index; Treatment Failure	2007
Comparative costs of ertapenem and piperacillin-tazobactam in the treatment of diabetic foot infections. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2007, May-15, Volume: 64, Issue:10 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Ertapenem; Female; Health Care Costs; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2007
Comment on: Best in class: a good principle for antibiotic usage to limit resistance development? The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:4 Topics: Bacterial Infections; beta-Lactams; Ertapenem; Humans	2007
Comparative in vitro activities of ertapenem (MK-0826) against 469 less frequently identified anaerobes isolated from human infections. Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests	2002
In vitro activity of ertapenem against bacterial isolates from cancer patients. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Neoplasms; Staphylococcus; Streptococcus	2002